The Story of Hope for Two Members: Zoila Pasos & Haydee Marte

Article

In 2007, Zoila Pasos found a lump in her breast when she was just a few weeks pregnant. Not long into the pregnancy, she miscarried. While she allowed her body time to heal, she had the lump checked and was told it was a benign cyst and nothing to worry about.

In 2007, Zoila Pasos found a lump in her breast when she was just a few weeks pregnant. Not long into the pregnancy, she miscarried. While she allowed her body time to heal, she had the lump checked and was told it was a benign cyst and nothing to worry about.

Six months later, Zoila was expecting again. Around 12 weeks, she decided to move from Miami back to her native California. She noticed that the lump in her breast was growing, but chalked it up to the pregnancy hormones.

When she finally saw her obstetrician to begin prenatal visits, he scheduled an ultrasound for her baby, and for the lump. Zoila’s additional genetic screening also indicated a likelihood of downs syndrome, so she also needed amniocentesis. It was a busy week.

At the ultrasound the next day, Zoila discovered she was having twins! She was mostly shocked and excited, but still anxious about the amniocentesis. She wanted to make sure everything was okay with her two babies.

The day after her ultrasounds, she received a call from the doctor about the lump in her breast. A biopsy was the next step, and she needed it right away.

“The whole time, I just assumed my [breast] implant was leaking fluid,” said Zoila. “I was so worried about the amniocentesis and the results of that test, I never once dreamed that the lump was cancer.”

On December 26, 2007, Zoila’s obstetrician called and referred her to an oncologist. “What do you mean, an oncologist? Cancer?” Zoila was stunned.

When she saw the oncologist the next day, the news was grim. An abortion without delay was his recommendation. She had stage IIIc invasive ductal carcinoma breast cancer. The lump was seven centimeters big and the cancer had spread to her lymph nodes. It was literally feeding off of the increased estrogen produced because of being pregnant.

When she questioned the oncologist about keeping the babies, he saw no alternative.

“He basically refused to treat me. If I didn’t have an abortion, he did not want to be liable,” explained Zoila. “He did not give me any hope.”

Reluctantly, she went to the abortion clinic orientation. At the initial appointment, she walked out.

“I was going to die either way. If I went through with it [abortion], I would’ve died of depression,” Zoila said.

That’s when she went home and started researching. She found Hope for Two and Dr. Elyce Cardonick (maternal-fetal medicine specialist). She heard the words, “no, don’t have an abortion” and it was just what she needed.

Dr. Cardonick was able to refer her to a new oncologist at UCLA Medical Center who reassured her that she was going to be fine. Around that same time, Zoila received the great news from her amniocentesis test—her twin baby BOYS had perfect chromosomes!

Zoila received four rounds of chemotherapy during pregnancy. At 32 weeks—on April 4, 2008—she delivered Joel and Julian via planned cesarean. Two weeks later, her bundles of joy came home together.

Postpartum, she received six more rounds of chemo and underwent a double mastectomy. After surgery, infected lymph nodes threatened to complicate her recovery, but after four more rounds of chemo and seven weeks of radiation that ended four days before the boys turned one, she was cancer free.

2013

In 2013, Hope For Two called Zoila. A new member from New Jersey who only spoke Spanish had a similar cancer diagnosis, and she needed a support woman who could speak her language.

“Haydee had the same cancer as me, with an almost identical story,” said Zoila. “The initial lump, and being told it was nothing to worry about. It was when Haydee got pregnant and the lump grew that more tests revealed she had stage II invasive ductal carcinoma breast cancer.

Zoila and Haydee spoke every day. At the time, Zoila’s oldest daughter, Tatiana, was attending St. John’s in New York City. When Zoila went to visit her daughter, she made special trips to see Haydee.

“It was a tough time for Haydee, but she made it through and gave birth to a healthy baby boy, Emmanuelle, on March 30, 2014.” Zoila said.

With Haydee in remission, the daily calls have stopped, but the two continue to talk weekly, and exchange text messages and photos regularly.

“My boys are healthy, energetic six-year-olds in the first grade. To think that they wouldn’t have been here, if I had listened to that first doctor, it’s just incredible,” said Zoila.

“I had a support woman and was in touch with Dr. Cardonick throughout my entire journey. Hope for Two, and how it started—with the founders going through what we went through—was so inspiring, I decided I had to become a support woman,” she added.

Would you like to share the story of your pregnant with cancer journey? Contact us: info@hopefortwo.org.

Read more inspirational stories by Hope for Two members on our website: www.hopefortwo.org/survivor_stories.php

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.